A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies

Listen to The Lancet Haematology
40 min
A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies

Listen "A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies"

Descargar episodio Ver en sitio original

Episode Synopsis

With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is becoming ever more important. Join a panel of authors from The Lancet Haematology's latest series on Adverse Event reporting to discuss how we can improve clinical trial design and analysis, and translate this data to meaningful, patient-centric care.
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA